We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Formation of Adipose Scar Tissue Begins with Activation of Platelet-Derived Growth Factor Receptor Alpha Signaling

By LabMedica International staff writers
Posted on 08 Jun 2015
Researchers have found a link between activation of PDGFRalpha (platelet-derived growth factor receptor alpha) signaling in perivascular cells (such as pericytes, connective tissue cells that occur about small blood vessels) and the formation of scar tissue that can lead to metabolic dysfunction and development of chronic diseases such as diabetes.

Fibrosis is a common disease process in which pro-fibrotic cells disturb organ function by secreting disorganized extracellular matrix (ECM). More...
Adipose tissue fibrosis occurs during obesity and is associated with metabolic dysfunction, but how pro-fibrotic cells originate is as yet unknown.

In this regard, investigators at Oklahoma Medical Research Foundation (Oklahoma City, USA) used a developmental model to investigate perivascular cells in white adipose tissue (WAT) and their potential to cause organ fibrosis.

They reported in the May 27, 2015, online edition of the journal Genes & Development that activation of PDGFRalpha signaling in perivascular cells caused them to transition into ECM-synthesizing pro-fibrotic cells. Before this transition occurred, PDGFRalpha signaling up-regulated mTOR (mammalian target of rapamycin) signaling and ribosome biogenesis pathways and perturbed the expression of a network of epigenetically imprinted genes that had been implicated in cell growth and tissue homeostasis.

"Scarring can be an important part of the healing process when a person suffers an injury," said senior author Dr. Lorin Olson, assistant professor of immunobiology and cancer research at Oklahoma Medical Research Foundation. "But excessive scarring, or fibrosis, can contribute to many dangerous health conditions. When fat cells are surrounded by scar tissue, it inhibits their ability to store lipids. When that happens, the lipids are stored in places like the liver or muscle. That can cause insulin resistance, which can lead to diabetes. By studying the molecular mechanisms involved in the process, we will try to understand the role it may play in heart disease, diabetes and other metabolic disorders."

Related Links:

Oklahoma Medical Research Foundation



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Platelet Function Analyzer
PL-12
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.